Pharmacogenetics in Psychiatry

Daniel J. Müller

doi:10.1055/a-1212-1101

Pharmacopsychiatry, Table of Contents

Pharmacopsychiatry 2020; 53(04): 153-154
DOI: 10.1055/a-1212-1101

Editorial

Pharmacogenetics in Psychiatry

Authors

Daniel J. Müller

¹Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada

²Department of Psychiatry, University of Toronto, Toronto, ON, Canada

³Department of Pharmacology, University of Toronto, Toronto, ON, Canada

Abstract

This Special Issue on Pharmacogenetics in Psychiatry consists of five selected articles which encompass the first concepts of pharmacogenetics, to implementation strategies applyng pharmacogenetic testing into psychiatric clinical practice.

Full Text

References

References
1 Müller DJ, Rizhanovsky Z. From the Origins of Pharmacogenetics to First Applications in Psychiatry. Pharmacopsychiatry 2020; 53: 155–161
2 Brown L, Eum S, Haga SB et al. Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. Pharmacopsychiatry 2020; 53: 162–173
3 Fan M, Bousman CA. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines? Pharmacopsychiatry 2020; 53: 174–178
4 Menke A, Weber H, Deckert J. Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital. Pharmacopsychiatry 2020; 53: 179–183
5 Bättig VAD, Roll SC, Hahn M. Pharmacogenetic Testing in Depressed Patients and Interdisciplinary Exchange between a Pharmacist and Psychiatrists Results in Reduced Hospitalization Times. Pharmacopsychiatry 2020; 53: 185–192